12:00 AM
Jun 04, 2012
 |  BC Week In Review  |  Financial News  |  Completed Offerings

Cell Therapeutics completes private placement of convertible preferred stock and warrants

Cell Therapeutics Inc. (NASDAQ: CTIC; Milan:CTIC), Seattle, Wash.
Business: Cancer
Date completed: 5/29/12
Type: Private placement of convertible...

Read the full 68 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >